A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma

Spremljeno u:
Bibliografski detalji
Izdano u:J Transl Med
Glavni autori: Dummer, Reinhard, Daud, Adil, Puzanov, Igor, Hamid, Omid, Schadendorf, Dirk, Robert, Caroline, Schachter, Jacob, Pavlick, Anna, Gonzalez, Rene, Hodi, F Stephen, Cranmer, Lee D, Blank, Christian, O’Day, Steven J, Ascierto, Paolo A, Salama, April K S, Li, Nicole Xiaoyun, Zhou, Wei, Lis, Joy, Ebbinghaus, Scot, Kang, Peter S, Ribas, Antoni
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Oral Presentation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4315269/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-13-S1-O5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items